School of Nursing, The University of Hong Kong
Hong Kong
NCT Number: NCT04830072
This pilot randomized controlled trail aims to test the effects of AR enhanced pictorial effects in harms of smoking and benefit of smoking cessation.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Hong Kong
Conventional health warnings on smoking harms mostly include pictures showing smoking consequences such as lung diseases, peripheral vascular diseases, aging, skin lesions, and benefit of quitting such as improved cardiopulmonary functions, skin conditions and risk of diseases, etc. The effects of the information are limited by the generic messages, unattractive images, and lack of interaction. This proposal aims to enhance the "Warn" and "Advice" materials using mobile phone-based augmented reality (AR) technologies to provide personalized, interactive, and attractive images to encourage smokers to quit smoking.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The AWARD advice includes: (1) Ask about smoking history; (2) Warn about the high risk of smoking; (3) Advise to quit or reduce smoking as soon as possible; (4) Refer smokers to smoking cessation services (with a referral card); (5) Do it again: to repeat the intervention.
Participants in the intervention group will receive 3 months of chat-based support through Instant Messaging apps (e.g., WhatsApp, WeChat). The support mainly includes (1) regular messages on health warnings, benefits and methods of quitting, coping craving approach, and promotion to use the SC services; (2) real-time, personalized, and interactive behavioral and psychosocial support through Instant Messaging apps.
Leaflet on harms of smoking
AR images of the harms of smoking and the benefit of abstinence.
Time frame: 3 months after baseline
Abstain from smoking in the past 7 days
Time frame: 1 months after baseline
Abstain from smoking in the past 7 days
Time frame: 3 months after baseline
Defined by at least 50% reduction in baseline daily cigarette consumption
Time frame: 1 months after baseline
Defined by at least 50% reduction in baseline daily cigarette consumption
Time frame: 3 months after baseline
Defined by abstinence for at least 24 hours
Time frame: 1 months after baseline
Defined by abstinence for at least 24 hours
Time frame: 3 months after baseline
Defined by the recall of the quitline on warning pictures
Time frame: 1 months after baseline
Defined by the recall of the quitline on warning pictures
Time frame: 1 months after baseline
Defined by notice of pictorial warning
Time frame: 3 months after baseline
Defined by notice of pictorial warning
Time frame: 1 months after baseline
Defined by readiness to quit in 30 days
Time frame: 3 months after baseline
Defined by readiness to quit in 30 days
Time frame: 3 months after baseline
Defined by behaviors to avoid seeing pictorial warnings
Time frame: 1 months after baseline
Defined by behaviors to avoid seeing pictorial warnings
Time frame: 1 months after baseline
Defined by ratings on the effectiveness of AR images to encourage quitting
Time frame: 3 months after baseline
Defined by ratings on the effectiveness of AR images to encourage quitting
The University of Hong Kong
Other
Mobile Phone Based Personalized and Interactive Augmented Reality (AR) Pictures on Enhancing Brief Advice Model for Smoking Cessation: a Pilot Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05130788
Behavior, Health Behavior
New York, United States
View Trial DetailsNCT06663020
Behavior, Bronchial Neoplasms
Samsun, Turkey (Türkiye)
View Trial DetailsNCT04881630
Behavior, Health Behavior
Oklahoma City, Oklahoma, United States
View Trial DetailsNCT04620915
Behavior, Cancer
Eugene, Oregon, United States
View Trial Details